10x Genomics Inc. (TXG) at a glance

10x Genomics Inc. (TXG) is a mid-cap Healthcare company. It trades at $69, with a -3.5% profit margin and revenue decline of 2.6%. It does not pay a dividend. Vestovix scores it 38/100 overall. Its strongest dimension is Momentum (90/100) and its weakest is Safety (12/100). It carries above-market volatility, so expect larger swings.

Price

$69.00

Market cap

$3.66B

P/E ratio

n/a

Dividend yield

None

Beta

2.11

52-week range

$11.16 to $66.94